Collegium Pharmaceutical saw the highest growth of 2.99% in patent filings and no patents were granted in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 2.99% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of Collegium Pharmaceutical’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Collegium Pharmaceutical has been focused on protecting inventions in United States(US) with six publications in Q2 2024
The United States(US) Patent Office dominates the patent filings with nearly 100% of filings. The United States(US) patent Office are among the top ten patent offices where Collegium Pharmaceutical is filings its patents..
Patents related to addiction and rare diseases lead Collegium Pharmaceutical's portfolio
Collegium Pharmaceutical has the highest number of patents in addiction followed by, rare diseases. For addiction, nearly 60% of patents were filed and no patents were granted in Q2 2024.
Pain related patents lead Collegium Pharmaceutical portfolio followed by transmucosal drug delivery, and low back pain
Collegium Pharmaceutical has highest number of patents in pain followed by transmucosal drug delivery, low back pain, neuropathic pain (neuralgia), and opium (opioid) addiction.
For comprehensive analysis of Collegium Pharmaceutical's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
